Zambon launches intravenous formulation of Fluimucil
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
Prucalopride Tablets are bioequivalent to Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals USA
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
Subscribe To Our Newsletter & Stay Updated